Papers
3
Total Citations
26
H-Index
3
About
Li-Jen Wang is a clinician-scientist whose research focuses on the intersection of prostate cancer, advanced imaging, and metabolic risk factors. His work has been instrumental in refining diagnostic strategies for biochemically recurrent prostate cancer, particularly through a landmark 2020 study comparing 68Ga-PSMA-11 PET/CT with multiparametric magnetic resonance imaging in post-prostatectomy patients—a paper that has garnered 16 citations and helped shape imaging protocols in Taiwan. Wang has also made significant contributions to understanding how body composition and pelvic fat distribution influence prostate cancer aggressiveness and biochemical recurrence, with his 2022 study (7 citations) providing novel prognostic insights. Most recently, his 2024 investigation into periprostatic adipose tissue revealed a surprising natural barrier effect, where fat tissue secretes apoptotic factors that may inhibit tumor progression during early-stage disease—a finding that challenges conventional assumptions about obesity and cancer risk. By bridging radiology, oncology, and metabolic physiology, Wang’s work offers a multidimensional view of prostate cancer biology, with direct implications for personalized surveillance and treatment planning.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3